Life Insurance: Aviva India Next Innings Pension

Aviva India Next Innings is a pension plan that returns more than double of what you have...

Premium Content
Monthly Digital Access


Already A Subscriber?
Yearly Digital+Print Access


Moneylife Magazine Subscriber or MSSN member?

Yearly Subscriber Login

Enter the mail id that you want to use & click on Go. We will send you a link to your email for verficiation
Rajiv Gandhi Jeevandayee Arogya Yojana: First beneficiary bogus?

The first beneficiary in Maharashtra, who received health card from Sonia Gandhi, is not poor as claimed, but owns a well-built home that has an air conditioner, claims ABP Mazha

According to a news report from the channel, Shakuntala Bhagat, who was handed over the health card by none other than United Progress Alliance (UPA) chairperson and Congress chief Sonia Gandhi at the Kasturchand Park in Nagpur on 21st November, owns an eight room house in Wadi village. Bhagat uses six rooms for her family, while two are given on rent.


Bhagat's home has TV set, sofa set, bed, good kitchen, gas stove and other necessary furniture. She even owns an air conditioner. Bhagat who wears a thick golden chain had studied till sixth standard. Her family consists of her two sons, two daughter-in-laws and grandchildren. One of her sons is in transportation business and owns two trucks. Bhagat's other son works in a private company.


Surprisingly, as per the terms and conditions of RGJAY, the beneficiary's total annual income should be less than Rs1 lakh. However, looking at the living standard of Bhagat, the first beneficiary of the Scheme in Maharashtra, it looks like the real beneficiaries would be again deprived benefits of social scheme as usual.


Local Congress leaders who proposed Bhagat’s name, played ignorance about the financial condition of Bhagat while speaking with the news channel.


The health card facilitates free surgeries of 971 different kinds, including kidney and heart operations, costing up to Rs1.5 lakh for 2.11 crore potential beneficiaries in the state (with annual income up to Rs1 lakh) at any of the empanelled private and government hospitals.



Vaibhav Dhoka

3 years ago

A routine fraud played on people to grab publicity.


3 years ago

Shakuntala Bhagat as an individual may have an actual annual income of less than Rs one lakh and if so she is eligible to Jeevandayee Arogya Yojana health card. Other than retired Govt staff others don't have Pension and with this in mind only old age Pension are given in Many States and one must not forget today Medical treatment involving hospitalisation is beyond reach for even families with annual income of Rs 3 lakhs and fact is most of Nursing Homes are run by mercinaries


Thomas Kuruvilla

In Reply to TIHARwale 3 years ago

You seem to have missed the point. Any welfare scheme should be targeted first at the poorest of the poor. From the article, Mrs Bhagat can in no way be said to fall in that category. There is no doubt that medical treatment is expensive, especially in the private sector. That is why there are Govt. hospitals where treatment is given nearly free. I personally have nothing against welfare schemes but they should reach the right people without pilferage on the way. Unfortunately, this is not the case in our country.

Wyeth to merge with Pfizer for creating a single brand

Pfizer made 52-week high on announcement, on news that it is to merge with wyeth for creating single Pfizer brand, to expand across multiple therapeutic categories

Pfizer India Ltd (Pfizer) and Wyeth India Ltd (Wyeth), said their board of directors in their respective meetings on Monday, approved a proposal to merge Wyeth with Pfizer.

Based on the proposed merger swap ratio, Pfizer will issue around 1.59 crore new equity shares to Wyeth shareholders, as consideration for the merger.  The shareholders of Wyeth will get seven shares of Pfizer for every ten shares of the company (Wyeth).

“The combined entity would have an increased therapeutic presence and a de-risked business profile. The merger process would require several approvals and we anticipate this will take approximately another nine months,” said Aijaz Tobaccowalla, managing director, Pfizer and Wyeth.

Pfizer and Wyeth are going to merge for creating a single Pfizer brand. It will help company to strengthen the India operations through expansion across multiple therapeutic categories, unifies management focus and combines the talent pool, Increases long-term value for all stakeholders.


Pharmaceuticals companies Pfizer and Wyeth have also announced an interim dividend of Rs360 per share and Rs145 per share respectively.

The merger process is expected to be completed in over next nine months after getting the key approvals from shareholders of Pfizer and Wyeth. Approvals from SEBI, stock exchanges, Foreign Investment Promotion Board (FIPB), Jurisdictional High Court of Bombay are required for the merger as well.

On Monday, Pfizer hits its 52-week high at Rs1,648 before closing 12.14% up at Rs1,605 while Wyeth ended the day 13.6% higher at Rs924.80 on BSE. The BSE 30-share benchmark closed 387 points up at 20,605.


We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)